Annual report pursuant to Section 13 and 15(d)

Schedule of Discontinued Operation of Unaudited Balance Sheet and Operation Statement (Details)

v3.25.0.1
Schedule of Discontinued Operation of Unaudited Balance Sheet and Operation Statement (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]    
Accounts payable $ 1,425,083 $ 1,425,083
Accrued expenses [1] 7,666,630 520,051
Finance lease [2] 220,461 220,461
Current liabilities of discontinued operations 9,312,174 2,165,595
Other (expense) income, net [3] (7,195,076) 56,844
Provision for income taxes
(Loss) income from discontinued operations $ (7,195,076) $ 56,844
[1] Included in accrued expenses at December 31, 2023 was $7.3 million awarded to CIGNA Health under the terms of a lawsuit, which is more fully discussed in Note 14.
[2] As of December 31, 2023 and 2022, the Company was in default under the finance lease obligation. Therefore, the aggregate future minimum lease payments under this finance lease totaling $0.2 million are deemed to be immediately due.
[3] Included in other expense for the year ended December 31, 2023 was $7.3 million awarded to CIGNA Health under the terms of a lawsuit, which is more fully discussed in Note 14.